SCHEMBL30455380

SCHEMBL30455380

CCNc1nc(NCc2ccco2)c2cc(OC)c(OC)cc2n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 7/20 0.65
KDM4E B2RXH2 7/20 0.58
MAPT P10636 7/20 0.58
NPSR1 Q6W5P4 5/20 0.58
RECQL P46063 1/20 0.58
KMT2A Q03164 4/20 0.56
MEN1 O00255 2/20 0.56
BLM P54132 1/20 0.56
BCHE P06276 2/20 0.54
ACHE P22303 2/20 0.54
F2RL1 P55085 1/20 0.54
PDE5A O76074 1/20 0.51
ALDH1A1 P00352 5/20 0.48
LMNA P02545 5/20 0.48
HPGD P15428 3/20 0.48
GAA P10253 2/20 0.48
ALOX15 P16050 2/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
SOS1 Q07889 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25246787 0.84 F2RL1 (0.56) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL25289885 0.84 MAPK1 (0.68) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL27253694 0.82 MAPK1 (0.65) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL30455471 0.81 MAPT (0.72) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL31620256 0.81 MAPK1 (0.64) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL27253793 0.81 MAPK1 (0.64) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL31620252 0.81 MAPK1 (0.64) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL27253683 0.81 MAPK1 (0.64) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL25246241 0.81 KDM1A (0.58) MAPK1KDM4EMAPTNPSR1RECQL
SCHEMBL31620250 0.80 MAPK1 (0.62) MAPK1KDM4EMAPTNPSR1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF UNIV AJOU IND ACADEMIC COOP FOUND (KR) 2025-02-13 US disclosed
WO-2023121429-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF 아주대학교산학협력단 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF ADORA2A, HCRTR1, ADORA1 MAPK1 2480/4885KDM4E 1094/4885MAPT 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.